| Scientists from Shanghai Institute of Materia Medica ( SIMM ) , CAS made progress in demonstrating the therapeutic opportunities of histone deacetylases ( HDACs ) inhibitors in combination with clinically available drugs in triple-negative breast cancer .The finding was published in Cancer Cell on Sept 12 .SIMM professors GENG Meiyu , DING Jian and HUANG Min are corresponding authors of this article .Full text link ： http : / / www . cell . com/cancer-cell/fulltext/S1535-6. |
